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Obesitas merupakan faktor protektif terhadap terjadinya tuberculosis
paru (TB Paru) pada populasi non-diabetes. Namun, pengaruh obesitas
pada pasien dengan diabetes melitus tipe II (DMT2) belum banyak
diketahui. Studi ini bertujuan untuk mengetahui hubungan obesitas dan
TB Paru pada pasien dengan DMT2. Studi merupakan studi potong lintang
yang dilakukan di instalasi rawat inap, Departemen Penyakit Dalam, Rumah
Sakit Umum Pusat Fatmawati pada bulan Januari 2015 sampai dengan
Desember 2017. Kriteria inklusi pada penelitian ini adalah pasien DMT2
yang telah terdiagnosa dengan TB paru dan berusia > 18 tahun. Pada
studi ini, hasil Bakteri Tahan Asam (BTA) negative didef inisikan sebagai
tidak ditemukannya BTA pada pemeriksaan mikroskopik sputum subjek,
sementara obesitas didefinisikan sebagai index massa tubuh > 24.9 kg/
m2. Dari 363 subjek dengan TB paru dan DMT2, 22.59% subjek
mengalami obesitas. Prevalensi BTA negative pada pasien dengan TB
paru dan DMT2 adalah 81.82%, temuan tersebut diketahui berhubungan
dengan kejadian obesitas (p:0.002, OR=6.36, 95%CI 1.9-21). Kesimpulan
dari penelitian ini adalah pada pasien TB paru dan DMT2 dengan obesitas,
hasil pemeriksaan sputum cenderung memberikan hasil negative. Oleh
karena, itu perlu kewaspadaan dalam mendiagnosa TB paru pada pasien
dengan DMT2 yang mengalami obesitas, karena tidak dapat semata-
mata disingkirkan hanya berdasarkan hasil pemeriksaan sputum.
Obesity is known as protective factors of pulmonary tuberculosis (PTB) in
non-diabetes mellitus population. However, it’s effect on PTB in type 2
diabetes mellitus (T2DM) patient is unclear. The study aims to determine
the association between obesity and PTB in patient with T2DM. A cross-
sectional study was held in in-patient, The Department of Internal Medi-
cine, Fatmawati General Hospital from January 2015 to December 2017.
This study includes patient with T2DM who had been diagnosed with PTB
and age > 18 years old. In this study negative Acid-fast-bacilli (AFB)
founding def ined as patient’s sputum is negative by smear microscopy,
while obesity def ine as body mass index > 24.9 kg/m2. From 363 PTB
patient with T2DM, 22.59% were obese. Results showed that prevalence
of negative AFB founding in PTB patients with T2DM was 81.82% and it
was solely associated with obesity (p:0.002, OR=6.36, 95%CI 1.9-21). Obese
patients were likely to have negative AFB founding. It suggested that
diagnosing PTB in patient with T2DM and obese can’t be solely based on
bacteriological conf irmation.
Tuberculosis is the ninth leading cause of death
worldwide. It was estimated 10.4 million incident cases
of TB worldwide in 2016.1 Most of the estimated
number (45%) occurred in South-East Asia, including
Indonesia.1 The increase of non-communicable disease
such as diabetes is recognized as a re-emerging risk
and challenge to tuberculosis control. Epidemiological
studies have elucidated the association between
diabetes and tuberculosis, people with diabetes have
triple risk of developing tuberculosis, and 15% of TB
cases globally were linked to diabetes.2-5
Since diabetes prevalence has increased
worldwide, the risk of having obesity as result of
lifestyle changes, population aging, and urbanization
was also increased. Obesity is known as major
However, obesity has long known as protective
factors of pulmonary tuberculosis (PTB).7-9 The effect
of obesity on tuberculosis suggested that obese
individual had more CD4+ T cells and leptin hormone
which was play important role in immune protection
and reduce the risk of active tuberculosis. 10-12
Unfortunately, the effect of obesity on PTB in type 2
diabetes mellitus (T2DM) patient is unclear.
The aim of this study is to know the association
between obesity and acid-fast bacterial f inding (active
tuberculosis) in patient with PTB and T2DM, and
investigated the factors affecting negative bacterial
f indings in patient with PTB and T2DM.
6 8
Jurnal Epidemiologi Kesehatan Indonesia Vol. 3, No. 2, Desember 2019
Methods
A cross-sectional study held in in-patient,
department of Internal Medicine, Fatmawati General
Hospital from January 2015 to December 2017 through
consecutive sampling method with a minimum study
subject calculated using Lemeshow formula
(P1=0.0317, P2=0.2167, a 5% (Za/2=1.96), and Z1-
b=0.84 for power 80%), we got 50 subjects for each
group as minimum sample for our study.   We use
secondary data from medical records of patients
admitted with following inclusion criteria: patients with
type 2 diabetes mellitus, diagnosed with pulmonary
tuberculosis and age > 18 years old. The exclusion
criteria were patient without bacteriological
confirmation data or Body Mass Index (BMI) data or
diagnosed with miliary TB.
From 383 PTB patients with T2DM who
admitted to our hospital, we found 363 patients eligible
to conducted in our study. Negative acid fast-bacilli
founding defined as patient’s sputum is negative by
smear microscopy or Xpert MTB/RIF, while obesity
def ine as body mass index > 24.9 kg/m2 as
recommended by World Health Organization (WHO)
Asia-Pacif ic Task Force.13 Educational status was
categorized by high (university and high school
graduates) and low (below high school graduate).
Category for glycemic control used HbA1c and fasting
blood glucose (FBG) level which was divided into poor
(HbA1c > 7% or FBG < 80 mg/dL or > 130 mg/dL) and
good (HbA1c< 7% or FBG  80-130 mg/dL) according
to Indonesian society for endocrinology (PERKENI)
guidelines. Duration of diabetes was def ined as length
time since patient get diagnosed with diabetes until
current admission.
The data analyses were performed using STATA
version 12. All data were expressed in categorical
parameters. Chi-square test was performed to f ind
an association between obesity and AFB-founding in
PTB patient with T2DM. Multivariate analysis using
logistic regression was performed to find an association
between obesity and AFB-founding in PTB patient with
T2DM after controlling covariate variables. All p values
Results
From 383 patients between January 2015-
December 2019, 363 patients met the inclusion and
without exclusion criteria. From 363 subjects, 22.59%
were obese and 81.82% were found negative in acid-
fast bacilli examination. Most of the subjects were age
< 60 years old (65.29%), female (62.29%), high
educational  status  (63.89%),  non-smoking  (69.55%),
poorly controlled HbA1c (75.61%), poorly controlled FBG
(74.78%) and has been diagnosed with T2DM < 10 years
(85.77%) (Table 1).
Table 1 .  Demographic and Cl in ical  Char acter is t ics  of The
Sub jec t s
Characteristics N (%) 
Body Mass Index  
 Obese  82 (22.59) 
 Not-obese 281 (77.41) 
Acid-fast bacilli founding  
 Negative  297 (81.82) 
 Positive  66 (18.18) 
Age  
 < 60 years 237 (65.29) 
 > 60 years 126 (34.71) 
Sex  
 Female 226 (62.26) 
 Male 137 (37.74) 
Educational status  
 High 220 (63.89) 
 Low 130 (36.11) 
Smoking   
 No 233 (69. 55) 
 Yes 102 (30.45) 
HbA1ccontrol  
 Good  30 (24.39) 
 Poor   93 (75.61) 
FBG Control   
 Good 58 (25.22) 
 Poor 172 (74.78) 
Duration of diabetes  
 < 10 years 223 (85.77) 
 > 10 years 37 (14.23) 
 
Table 2. Association Between Obesi ty and Acid-Fast Baci l l i
Founding In PTB Pat ients  with T2DM
 
 
  
Variable Total  
n (%) 
AFB Negative 
n (%) 
Bivariate 
OR (95% CI) p-value  
Body mass index     
 Obese  82 (22.59) 77 (93.90) 4.27 (1.64-14.08) 0.001 
Age      
 > 60 years 126 (34.71) 108 (85.71) 1.52 (0.82-2.93) 0.161 
Sex     
 Male 137 (37.74) 113 (82.48) 1.07 (0.60-1.96) 0.799 
Educational Status     
 Low 130 (36.11) 97 (74.62) 0.48 (0.27-0.85) 0.007 
Cigarette     
 Yes 102 (30.45) 81 (79.41) 0.78 (0.42-1.48) 0.398 
HbA1c control     
 Poor  93 (75.61) 70 (75.27) 0.47 (0.15-1.46) 0.190 
FBG control     
 Poor 172 (74.78) 140 (81.40) 0.80 (0.31-1.88) 0.595 
Length of T2DM 
diagnosed 
    
 > 10 years 37 (14.23) 33 (89.19) 1.91 (0.65-5.62) 0.236 
 
Negative acid-fast bacil l i  founding was
signif icantly more common in obese PTB patient with
T2DM, risk of negative AFB founding in obese patient
with T2DM was nearly 4.3 fold higher than those without
obese (p: 0.001, odds ratio [OR] = 4.27, 95% Confidence
Interval [CI] 1.64-14.08). However, negative AFB founding
was less common in patient with low educational status
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(p: 0.007, OR=0.48, 95% CI 0.27-0.85) (table 2).
Meanwhile, the effect of obesity increased (p: 0.002,
OR=6.36, 95% CI 1.9-21) when analyzed together with
another factors. Factors of age, HbA1c and FBG control
and length of T2DM diagnosed were not included in
the multivariate analysis because of their cell’s values
were too small (Table 3).
Table  3. Mult ivar iate Analys is
Variabel Beta  SE OR 95%CI P-value 
Obesity 1.85 0.61 6.36 1.9-21 0.002 
Educational status  -0.48 0.31 0.62 0.1-1.7 0.114 
Smoking   -0.32 0.35 0.73 0.8-16.6 0.368 
Sex -0.26 0.28 0.77 0.1-2.0 0.458 
 
Discussion
Our study showed that obesity were
signif icantly associated with negative AFB founding in
PTB patients with T2DM. Our results are consistent with
those of several published studies,  Lai Y et al. 2017.
Reported a lower risk of active tuberculosis in obesity
and overweight patient.11 Leung G et al. 2015. Reported
obesity is associated with a lower risk of active
tuberculosis in older population of Hongkong.7
Umakanth M, 2017. Reported obesity and overweight
were associated signif icantly with lower risk of both
clinically active and cultured-conf irmed tuberculosis.14
This f indings indicate that obesity is still a protective
factor in development of active tuberculosis even in
T2DM patients. This results also suggested that
screening or diagnosing tuberculosis especially in
obese patient with T2DM are not suff icient enough if
the test is just solely by sputum smear or geneXpert
MTB/Riff test.
This mechanism could be explained as people
with obesity has an increased frequency of CD3+ and
CD4+ T cells.10 Leptin levels are suppressed in
tuberculous patients and low leptin levels may
contribute to increase susceptibility to infections. In
humans, leptin levels are correlated with fat mass and
can be decreased by hunger.15 Recent studies showed
that basal leptin levels in obese patients are significantly
higher than non-obese patients.16 The administration
of leptin in patients with human congenital leptin
deficiency has demonstrated beneficial effect on T-
cell hyporesponsiveness, obesity, neuroendocrine and
metabolic def iciency.7 The immune-modulating effect
of leptin may also account for the lower risk of active
TB incidence in obese/overweight person since it could
enhance the T-cell-mediated immune function.17
this might produce bias since not all patients who had
negative test results on sputum smear test were went
to geneXper t MTB/riff examinations. Also, the
covariates presented in this study may not be suff icient
to conclude that the associations between obesity and
negative AFB f indings in PTB patients with T2DM are
truly independent. For example, pharmacological
treatment, recent TB diagnosis and comorbidities which
may have effects on these association were not
included in this study. Another (major) limitations of
our study is causal relations and postulated relationships
cannot be established from a cross-sectional study
design. With the potential clinical implications of our
observation, further cohort studies are warranted to
conf irm these f indings in other population groups.
More basic research and animal studies are also
indicated to explore underlying mechanisms.
Conclusion
Obesity associated with developing negative
AFB f indings in microbiological test for PTB in patients
with T2DM. Therefore, it suggested that clinicians
should conduct suff icient diagnosis test for PTB in
obese patient with T2DM even if AFB findings were
negative.
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